The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TRYbeCA-1: A randomized, phase III study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441).
 
Pascal Hammel
Honoraria - Celgene
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; ERYTECH Pharma (Inst); Halozyme; Mylan; Rafael Pharmaceuticals; VECT-HORUS
Speakers' Bureau - AstraZeneca; Celgene; ERYTECH Pharma; SERVIER; Shire
Research Funding - AstraZeneca (Inst); Celgene (Inst); ERYTECH Pharma (Inst); Halozyme (Inst)
Travel, Accommodations, Expenses - Halozyme; Ipsen; Pfizer/EMD Serono; Shire; Vect-Horus
 
Rossana Berardi
Consulting or Advisory Role - Boehringer Ingelheim; Otsuka
 
Geert-Yan Creemers
No Relationships to Disclose
 
Antonio Cubillo
No Relationships to Disclose
 
Eric Van Cutsem
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Halozyme; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Roche; SERVIER
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst)
 
Richard Greil
Honoraria - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Merck; MSD; Novartis; Roche; Sandoz; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Janssen; Merck; MSD; Novartis; Roche; Takeda
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gilead Sciences (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Sandoz (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen-Cilag; MSD; Novartis; Roche
 
Teresa Macarulla
Consulting or Advisory Role - Baxalta; Baxter; Celgene; Incyte; Ipsen; Lilly; QED Therapeutics; Roche; Sanofi/Aventis; SERVIER; Shire
Research Funding - Agios (Inst); ASLAN Pharmaceuticals (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); Genentech (Inst); Halozyme (Inst); Immunomedics (Inst); Lilly (Inst); Merrimack (Inst); Millennium (Inst); Novartis (Inst); Novocure (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Celgene; H3 Biomedicine; Merck; Sanofi; SERVIER
 
Jean-Philippe Metges
Honoraria - Bristol-Myers Squibb; Lilly; Novartis; Sanofi; SynCoreBio
Travel, Accommodations, Expenses - Amgen; Amgen; LEO Pharma; MSD Oncology; MSD Oncology; MSD Oncology
 
Marcus Smith Noel
Consulting or Advisory Role - Celgene; Taiho Pharmaceutical
Speakers' Bureau - Celgene; Taiho Pharmaceutical
 
Peter Nygren
Stock and Other Ownership Interests - Oncopeptides; Repos Pharma AB
Patents, Royalties, Other Intellectual Property - Repos Pharma AB
 
Pia J. Osterlund
Consulting or Advisory Role - Amgen; Bayer; Celgene; Eisai; Incyte; Lilly; Merck; MSD Oncology; Roche; Sanofi; Servier/Shire
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); ERYTECH Pharma (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); MSD (Inst); Nordic Drugs (Inst); Roche (Inst); Sanofi (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Abbvie; AstraZeneca (Inst); Merck (Inst); Roche (Inst)
 
Thomas Seufferlein
Honoraria - Amgen; Baxalta; Bayer Schering Pharma; Celgene; Falk Foundation; Halozyme; Merck Serono; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Baxalta; Bayer; Celgene; Halozyme; Merck Serono; Roche/Genentech; Shire
Research Funding - Celgene; Sanofi
Travel, Accommodations, Expenses - Celgene; Merck Serono; Roche; Sanofi; SERVIER
 
Harpreet Singh Wasan
Honoraria - Array BioPharma; Celgene; ERYTECH Pharma; Merck KGaA; Roche/Genentech; Servier; Shire; Sirtex Medical
Consulting or Advisory Role - ERYTECH Pharma; Incyte; Pierre Fabre; Roche Pharma AG; Shire; Sirtex medical
Speakers' Bureau - Celgene; Merck KGaA; SERVIER; Sirtex Medical
Research Funding - Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Sirtex Medical (Inst)
 
Anu Gupta
Employment - Erytech Pharma
Stock and Other Ownership Interests - Erytech Pharma
 
Linda Marie Grummer
Employment - Erytech Pharma
Stock and Other Ownership Interests - Erytech Pharma
 
Nigel Biswas-Baldwin
Employment - Erytech Pharma
Stock and Other Ownership Interests - Erytech Pharma
 
Richard Kay
No Relationships to Disclose
 
Hagop Youssoufian
No Relationships to Disclose
 
Iman El-Hariry
Employment - ERYTECH Pharma
Leadership - ERYTECH Pharma
Stock and Other Ownership Interests - ERYTECH Pharma
Travel, Accommodations, Expenses - ERYTECH Pharma
 
Manuel Hidalgo
Stock and Other Ownership Interests - Agenus; BioOncotech; Champions Oncology; Nelum Corp.; Pharmacyte Biotech
Honoraria - Agenus; InxMed; Pharmacyte Biotech; Takeda
Consulting or Advisory Role - Agenus; Bayer; Oncomatrix; Pharmacyte Biotech; Takeda
Research Funding - BiolineRx; ERYTECH Pharma
Patents, Royalties, Other Intellectual Property - Royalties from Myriad for PALB2 patent
Expert Testimony - Myriad Genetics
Travel, Accommodations, Expenses - Bayer; BiolineRx; Celgene; Menarini